Pipeline Snapshot as of November 3, 2026
Our global Research & Development (R & D) colleagues are the foundation of our innovative product pipeline. Explore our major R & D centers to discover the latest breakthroughs we’re working on.
Combining state-of-the-art R&D and Pfizer Global Supply (PGS) facilities with flexible, multi-product manufacturing capabilities, Andover is a key driver of innovation across our biologics discovery, development, and global clinical and commercial supply efforts.
Utilizing advanced laboratories and equipment, researchers in Bothell are dedicated to revolutionizing cancer treatment.
Located in Kendall Square, our Cambridge site interlaces Pfizer’s R&D capability with the densest biomedical community in the world.
Many of the discoveries and innovations that drive the Pfizer pipeline to new potential occur in the world-class research and development laboratories in Groton.
With more than 500,000 square feet of state-of-the-art facilities, this is where our scientists discover and develop cutting-edge cancer therapies using advanced laboratories and equipment.
As the global hub for Pfizer Vaccine Research and Development, our Pearl River colleagues have developed and manufactured vaccines and other medicines for more than a century.
An expansive laboratory and manufacturing space, our colleagues focus on the development of potential new medicines to help prevent or treat diseases and conditions.
Obesity is a complex, chronic disease. Managing obesity isn’t just about losing weight—it’s also about keeping it off. That’s a difficult prospect for many, but not because of a lack of discipline. The body is biologically designed to resist sustained weight loss.
For six seasons, the Science Will Win podcast has tackled topics at the forefront of healthcare and science.
Pfizer reported third-quarter 2026 results on November 3 that exceeded the company’s expectations. The company’s strong commercial performance.